Literature DB >> 9691563

What does treatment of depression really cost?

T W Croghan1, R L Obenchain, W E Crown.   

Abstract

This DataWatch presents estimates of the health care charges for adults who are diagnosed and treated for depression in primary care. More than nine out of ten of these adults sought care for at least one nondepressive illness during the year following treatment initiation. One average, these conditions accounted for more than 70 percent of the total charges. Attempts to manage the costs of caring for depressed persons must consider the impact of nondepressive illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691563     DOI: 10.1377/hlthaff.17.4.198

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  11 in total

1.  Does managing behavioral health care services increase the cost of providing medical care?

Authors:  B J Cuffel; W Goldman; H Schlesinger
Journal:  J Behav Health Serv Res       Date:  1999-11       Impact factor: 1.505

2.  Current issues in the economics of depression management.

Authors:  D Thompson; E Richardson
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 3.  The effect of managed care on prescription drug costs and benefits.

Authors:  A Lyles; F B Palumbo
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

Review 4.  Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment.

Authors:  Julie M Donohue; Harold Alan Pincus
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 5.  The economics of selective serotonin reuptake inhibitors in depression: a critical review.

Authors:  L Frank; D A Revicki; S V Sorensen; Y C Shih
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

Review 6.  The need for an iterative process for assessing economic outcomes associated with SSRIs.

Authors:  T L Skaer; D A Sclar; L M Robison; R S Galin
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

7.  Cost implications for the use of inhaled anti-inflammatory medications in the treatment of asthma.

Authors:  R J Ozminkowski; S Wang; W D Marder; J Azzolini; D Schutt
Journal:  Pharmacoeconomics       Date:  2000-09       Impact factor: 4.981

8.  The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study.

Authors:  Hillary R Bogner; Mark S Cary; Martha L Bruce; Charles F Reynolds; Benoit Mulsant; Thomas Ten Have; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2005-10       Impact factor: 4.105

Review 9.  Depression Treatment Expenditures for Adults in the USA: a Systematic Review.

Authors:  Aaron Samuel Breslow; Nathaniel M Tran; Frederick Q Lu; Jonathan E Alpert; Benjamin Lê Cook
Journal:  Curr Psychiatry Rep       Date:  2019-09-21       Impact factor: 5.285

10.  Patterns of medical resource and psychotropic medicine use among adult depressed managed behavioral health patients.

Authors:  Francisca Azocar; Loren M McCarter; Brian J Cuffel; Thomas W Croghan
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.